Agios Pharmaceuticals
AGIO
$34.54
Share price
-0.12%
Change (1 day)
40.29%
Change (1 year)
Categories
Market capitalization of Agios Pharmaceuticals (AGIO)
Market cap: $1.96 Billion
As of May 2024 Agios Pharmaceuticals has a market cap of $1.96 Billion. This makes Agios Pharmaceuticals the world's 4145th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Agios Pharmaceuticals from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.96 B | 57.54% |
| 2023 | $1.24 B | -19.32% |
| 2022 | $1.54 B | -13.57% |
| 2021 | $1.78 B | -40.52% |
| 2020 | $3.00 B | -8.12% |
| 2019 | $3.26 B | 21.67% |
| 2018 | $2.68 B | -3.69% |
| 2017 | $2.78 B | 58.98% |
| 2016 | $1.75 B | -28.36% |
| 2015 | $2.44 B | -41.13% |
| 2014 | $4.15 B | 456.23% |
| 2013 | $0.74 B |
End of Day market cap according to different sources
On May 4th, 2024 the market cap of Agios Pharmaceuticals was reported to be:
$1.96 Billion
$1.96 Billion
$1.94 Billion
$1.96 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $157.47 B | 7,930.60% | 🇺🇸 USA |
 Eli Lilly LLY | $698.51 B | 35,521.66% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $88.69 B | 4,423.19% | 🇬🇧 UK |
 Xencor XNCR | $1.48 B | -24.20% | 🇺🇸 USA |
 Exelixis EXEL | $6.37 B | 225.32% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $15.65 B | 698.28% | 🇺🇸 USA |